No peer-reviewed human clinical trials for 5-Amino-1MQ have been published to date
Kastenmller received funding (through their institutions) from the National Institutes of Health/National Institute on Aging through grants RF1AG058942, RF1AG059093, U01AG061359, U19AG063744, R01AG069901, and R01AG081322
It reflects the pharmacological action of the medication working as designed
Lindberg 2002)
Although the evidence is minimal for the influence of GST polymorphisms of the alpha, mu, pi, and theta classes on susceptibility to various types of cancer, numerous studies have implicated such genotypic variations in asthma, atherosclerosis, allergies, and other inflammatory diseases
We will not pad this article with consult your doctor disclaimers